Patents Examined by A. Hendricks
  • Patent number: 4581458
    Abstract: 4-Hydroxy-N-[5-[(substituted hetero)methyl]-3-isoxazolyl]-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides as agents for treating pain in mammals resulting from inflammation.
    Type: Grant
    Filed: October 12, 1984
    Date of Patent: April 8, 1986
    Assignee: Warner-Lambert Company
    Inventors: Jagadish C. Sircar, Thomas Capiris
  • Patent number: 4471123
    Abstract: Herbicidal isoxazolyl imidazolidinones are prepared by reaction of an isoxazolyl-allylurea with ozone and reduction.
    Type: Grant
    Filed: April 29, 1983
    Date of Patent: September 11, 1984
    Assignee: Eli Lilly and Company
    Inventors: David L. Varie, John C. Lechleiter
  • Patent number: 4456612
    Abstract: Described are compounds of the formula ##STR1## wherein X is hydrogen, loweralkyl, halo, loweralkoxy or trifluoromethyl, and Z is hydrogen, loweralkyl, halo, hydroxy or alkoxy, or compounds of the formula ##STR2## wherein X' and Y' may be the same or different and are selected from hydrogen, loweralkyl, or halo, and Z' is hydrogen, loweralkyl, halo, hydroxy or loweralkoxy, or pharmaceutically acceptable salts thereof.The compounds possess diuretic activity.
    Type: Grant
    Filed: February 23, 1983
    Date of Patent: June 26, 1984
    Assignee: Abbott Laboratories
    Inventors: Jacob J. Plattner, Anthony K. Fung
  • Patent number: 4452808
    Abstract: A series of new chemical compounds which are 4-aminoalkyl-2(3H)-indolones has been demonstrated to be D.sub.2 -agonists useful for treating hypertension. A representative compound of the series is 4-di-n-propylaminoethyl-2(3H)-indolone.
    Type: Grant
    Filed: December 7, 1982
    Date of Patent: June 5, 1984
    Assignee: Smithkline Beckman Corporation
    Inventor: Gregory Gallagher, Jr.
  • Patent number: 4427691
    Abstract: Novel 1,2-benzisoxazoloxyethylamines and intermediates for the preparation thereof are described. The 1,2-benzisoxazoloxyethylamines are useful as diuretic agents.
    Type: Grant
    Filed: February 25, 1981
    Date of Patent: January 24, 1984
    Assignee: Hoechst-Roussel Pharmaceuticals Inc.
    Inventor: Gregory M. Shutske